NPI Details
Nancy Tray, MD is an internal medicine in Monterey, CA with 14 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Nancy Tray, MD NPI is 1306112677. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2012
The provider's business location address is:
5 HARRIS CT., BLDG. T, STE. 201
MONTEREY, CA
ZIP 93940
Phone: (831) 375-4105
Fax: (831) 372-5722
The NPI 1306112677 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
- Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
- Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Injection, pembrolizumab, 1 mg (HCPCS:J9271)
- Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
- Injection, paclitaxel, 1 mg (HCPCS:J9267)
- Injection, fosaprepitant, 1 mg (HCPCS:J1453)
- Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
- Injection, heparin sodium, (heparin lock flush), per 10 units (HCPCS:J1642)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Injection, docetaxel, 1 mg (HCPCS:J9171)
- Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
- Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg (HCPCS:Q5116)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Injection, fluorouracil, 500 mg (HCPCS:J9190)
- Injection, carboplatin, 50 mg (HCPCS:J9045)
- Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
- Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
- Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
- Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
- Ferritin (blood protein) level (HCPCS:82728)
- Injection, zoledronic acid, 1 mg (HCPCS:J3489)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month (HCPCS:99491)
- Vitamin d-3 level (HCPCS:82306)
- Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
- Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Infusion into a vein for hydration, each additional hour (HCPCS:96361)
- Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
- Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
- Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
- Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
- Magnesium level (HCPCS:83735)
- Lactate dehydrogenase (enzyme) level (HCPCS:83615)
- Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
- Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
- Irrigation of implanted venous access drug delivery device (HCPCS:96523)
- Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
- Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
- Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
- Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
- Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
The enumeration date for this NPI number is 3/30/2012 and was last updated on 2/24/2020.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 390200000X | Student in an Organized Health Care Education/Training Program | | | | No |
| 2 | 207R00000X | Internal Medicine | | 275463 | NEW YORK | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | A162289 | OTHER | CALIFORNIA | MEDICAL BOARD OF CALIFORNIA |
